期刊文献+

鸡干扰素α1及胸腺肽α1融合蛋白原核表达系统的建立 被引量:2

Establishment of prokaryotic expression system of chicken IFNα1-THYα1 fusion protein
下载PDF
导出
摘要 根据GenBank已发表的鸡干扰素α1(IFNα1)基因序列,设计1对特异性引物,采用PCR方法,从鸡基因组中扩增出鸡IFNα1基因。根据胸腺肽α1(THYα1)氨基酸序列,选用大肠杆菌偏爱密码子,设计基因序列,同时在IFNα1-THYα1之间设计1个5肽Linker。在IFNα1基因结构基础上,设计4条寡核苷酸单链作为下游引物,以搭桥的方式延伸和扩增,最终获得IFNα1-THYα1融合基因;将该基因克隆至pGEX4T-1载体后,转化至BL21(DE3)受体菌中,37℃培养至菌液D600为0.6~1.0时,IPTG(1.0mmol/L)诱导培养4h;经western blot鉴定证实,成功构建了鸡干扰素α1及胸腺肽α1融合蛋白原核表达系统,表达产物以包涵体形式存在,获得高纯度的IFNα1-THYα1蛋白。以细胞病变抑制试验及E玫瑰花结形成试验对目的蛋白进行体外活性检测,结果显示该蛋白具有生物活性。 Accoding to the published genic sequences of chicken interferon-α1 ,a pair of specific primers was de signed to amplified the genc of chicken interferon-α1 by polymerase chain reaction (PCR) from the complete genome of chicken. Based on IFN α1 amino acid sequence and the choice of E. coli preference for the codon, we designed a linker of 5 peptides between IFN aland THY α1 and four oligonucleotide single chains as downszream primers. The IFN α1-THY α1 fusion gene was ohlained by PCR. The fusion gene was cloned into pGEX1T -1 expression plasmid and then transformed into BL21(DE3),cultured in liquid LB at 37℃ and induced with IPTG for 4 hours while its D600 got up to 0.6-1.0. Western blot results indicated that the chicken IFNα1 -THYα1 fusion protein have been successfully expressed and the product of expression exists as the form of inclusion. The high-purity of IFNα1 THYα1 protein was obtained and the activity in vitro of the purposed protein was detected with the cytopathogenic effect inhibition test and E rosette forming assay. The results proved that the protein possess the biological activity.
出处 《中国兽医学报》 CAS CSCD 北大核心 2008年第10期1185-1189,共5页 Chinese Journal of Veterinary Science
基金 国家自然科学基金资助项目(30740058)
关键词 干扰素α1 胸腺肽Α1 融合蛋白 纯化 chicken IFNα1 THYα1 fusion protein purification
  • 相关文献

参考文献14

  • 1郁子扬,张立煌.细胞因子重组融合蛋白研究进展[J].中国肿瘤生物治疗杂志,2004,11(2):148-150. 被引量:2
  • 2Buddaert W,Van Reeth K,Pensaert M. In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV) [J].Adv Exp Med Bio1,1998,440:461-467.
  • 3Giuseppe C V. Structure-activity of type Ⅰ interferons [J]. Biotherapy,1997,10(1) :59-86.
  • 4Guidotti L G, lshikawa T, Hobbs M V, et al. Intracellular inactivationof the hepatitis B virus by cytotoxic T lymphocytes [J]. Immunity, 1996,4 ( 1 ) : 478-483.
  • 5张学文,章怀云.干扰素诱导细胞抗病毒的分子机制[J].湖南农业大学学报(自然科学版),2001,27(1):79-83. 被引量:10
  • 6Maatta M, Soini Y, Liakka A, et al. Localization of MT1 - MMP,TIMP 1,TIMP-2, and TIMP-3 me senger RNA in normal, hyperplastic, and neoplastic Enha adenocarcinomas [J]. Am J Clin P nced expression by endometrical associated with low differentiationathol,2000,114 (3):402-411.
  • 7Weber F, Haller O. Viral suppression of the interferon system[J]. Biochimie, 2007, January : 836-842.
  • 8Saruc M, Long term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e a ntigen(HBeAg) negative ehornie hepatitis B[J]. J Pharm Sci,2003,92(7) :1386-1895.
  • 9闻玉梅.治疗性乙型肝炎疫苗的基础与应用研究[J].中华肝脏病杂志,2003,11(9):519-521. 被引量:19
  • 10Franco F 1,Diaz C,Barcia M,et al. Thymosin alpha 1 is a native peptide in severaltissues[J]. Biochim Biophys Acta,1992,1120(1) :43-48.

二级参考文献71

  • 1尚雪原,张世玲,焦波,鲁凤友,田刚,李凤才.胸腺免疫抑制组分的抗变态反应作用[J].中国药理学通报,1996,21(4):360-361. 被引量:1
  • 2张符光,刘佃辛,宋农,王新为,张兆山,马清钧.人胸腺素α原cDNA的克隆及在大肠杆菌中的表达[J].生物化学杂志,1996,12(4):386-390. 被引量:8
  • 3Schirmbeck R, Zheng X, Roggendorf M, et al. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J Immunol, 2001, 166: 1405-1413.
  • 4Psncholi P, Lee DH, Tackney C, et al. DNA prime/canarypos boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee. Hepatology, 2001, 33: 448-454.
  • 5Malanchere-Bres E, Payette PJ, Mancini M, et al. CpG oligodeoxynucleotides with hepatitis B surface antigen for vaccination in HBsAg-transgenic mice. J Virol 2001, 75: 6482-6491.
  • 6Preikschat P, Gunther S, Reinhold S, et al. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology, 2002, 35:466-477.
  • 7You Z, Huang XF, Hester J, et al. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway. J Immunol, 2000, 165: 4581-4591.
  • 8Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8(+)cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med, 2000, 191: 1269-1280.
  • 9Reignat S, Webster GJ, Brown D, et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med, 2002, 195: 1089-1101.
  • 10Kakimi K, Guidotti LG, Kezuka Y, et al. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med,2000, 192: 921-930.

共引文献63

同被引文献11

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部